NCT06156436View on ClinicalTrials.gov

A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
CroupBronchiolitisAsthma in ChildrenReactive Airway DiseasePneumoniaLower Respiratory Tract Infection
Interventions
DEVICE

ResAppDx v.20

Software application used to aid diagnosis of respiratory disorders

Trial Locations (5)

Unknown

Birmingham Children's Hospital, Birmingham

Bristol Royal Hospital of Children, Bristol

Leicester Royal Infirmary, Leicester

Evelina London Children's Hospital, London

The Royal London Hospital, London

All Listed Sponsors
lead

ResApp Health Limited

INDUSTRY

NCT06156436 - A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department | Biotech Hunter | Biotech Hunter